
Cytosorbents Corporation CTSO
$ 5.81
-1.36%
Cytosorbents Corporation PEG Ratio | CTSO
Annual PEG Ratio Cytosorbents Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.035 | -0.0244 | -0.0125 | -0.104 | -0.134 | 7.39 | 1.16 | 0.176 | -0.777 | 0.279 | -0.158 | 0.172 | 6.92 | -0.142 | 1.45 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.39 | -0.777 | 1.08 |
PEG Ratio of other stocks in the Medical devices industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Integra LifeSciences Holdings Corporation
IART
|
0.0116 | $ 14.54 | 1.18 % | $ 1.11 B | ||
|
Bruker Corporation
BRKR
|
-0.000023 | $ 62.25 | -5.4 % | $ 9.45 B | ||
|
LivaNova PLC
LIVN
|
0.0924 | $ 91.39 | -1.32 % | $ 4.99 B | ||
|
LENSAR
LNSR
|
-0.331 | $ 4.97 | -8.97 % | $ 59.4 M | ||
|
Orthofix Medical
OFIX
|
0.0448 | $ 7.12 | -9.94 % | $ 282 M | ||
|
Pulmonx Corporation
LUNG
|
0.121 | $ 2.81 | 0.18 % | $ 114 M | ||
|
InspireMD
NSPR
|
0.00883 | $ 0.78 | 9.49 % | $ 50.2 M | ||
|
InMode Ltd.
INMD
|
0.703 | $ 13.26 | -1.89 % | $ 857 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.34 | $ 33.43 | -1.65 % | $ 784 M | ||
|
Outset Medical
OM
|
-0.000079 | $ 4.22 | 2.43 % | $ 64.2 M | ||
|
PAVmed
PAVM
|
-0.00231 | $ 1.64 | 0.31 % | $ 1.1 M | ||
|
Sintx Technologies
SINT
|
-0.000373 | $ 1.56 | 4.36 % | $ 4.33 M | ||
|
AVITA Medical
RCEL
|
-0.16 | $ 17.62 | 2.92 % | $ 491 M | ||
|
Tandem Diabetes Care
TNDM
|
-0.0265 | $ 18.7 | 2.92 % | $ 1.27 B | ||
|
CHF Solutions, Inc.
CHFS
|
0.000741 | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
3.11 | - | -1.42 % | $ 435 M | ||
|
Itamar Medical Ltd.
ITMR
|
-0.619 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
0.21 | - | - | $ 462 M | ||
|
Intersect ENT, Inc.
XENT
|
0.164 | - | - | $ 955 M | ||
|
AdaptHealth Corp.
AHCO
|
0.163 | $ 7.72 | 4.97 % | $ 1.04 B | ||
|
CryoLife, Inc.
CRY
|
0.0508 | - | -4.14 % | $ 702 M | ||
|
Inspire Medical Systems
INSP
|
-0.307 | $ 62.36 | -3.06 % | $ 1.83 B | ||
|
Integer Holdings Corporation
ITGR
|
2.56 | $ 126.66 | 0.08 % | $ 4.4 B | ||
|
Avanos Medical
AVNS
|
0.00229 | $ 24.99 | - | $ 1.16 B | ||
|
Aziyo Biologics
AZYO
|
0.0913 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-0.00768 | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
-0.0254 | $ 1.83 | -4.69 % | $ 40.3 M | ||
|
Dynatronics Corporation
DYNT
|
-0.00181 | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
0.00041 | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
-0.0649 | - | - | $ 140 M | ||
|
GBS
GBS
|
-0.000035 | - | -0.57 % | $ 7.12 M | ||
|
NanoVibronix
NAOV
|
-0 | - | - | $ 1.08 M | ||
|
Ra Medical Systems
RMED
|
-0.00847 | - | 10.0 % | $ 610 K | ||
|
ReWalk Robotics Ltd.
RWLK
|
-0.000065 | - | 7.07 % | $ 66.1 M | ||
|
STRATA Skin Sciences
SSKN
|
-0.0321 | - | - | $ 6.6 M | ||
|
Abbott Laboratories
ABT
|
2.89 | $ 110.59 | 0.07 % | $ 193 B | ||
|
EDAP TMS S.A.
EDAP
|
0.0298 | - | - | $ 162 M | ||
|
Align Technology
ALGN
|
1.48 | $ 174.54 | 0.16 % | $ 12.7 B | ||
|
TELA Bio
TELA
|
0.0549 | $ 0.83 | -4.37 % | $ 39 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.52 | $ 104.0 | -0.68 % | $ 60.8 B | ||
|
Avinger
AVGR
|
-0.000778 | - | -20.74 % | $ 369 K | ||
|
CONMED Corporation
CNMD
|
1.1 | $ 51.21 | -1.42 % | $ 1.59 B | ||
|
Medtronic PLC
MDT
|
3.02 | $ 101.59 | -1.17 % | $ 130 B | ||
|
MiMedx Group
MDXG
|
-0.814 | $ 3.37 | 1.36 % | $ 498 M | ||
|
ThermoGenesis Holdings
THMO
|
-0.000124 | - | -25.84 % | $ 171 K | ||
|
Myomo
MYO
|
0.153 | $ 1.32 | -5.71 % | $ 55.2 M | ||
|
Insulet Corporation
PODD
|
1.29 | $ 148.03 | -1.19 % | $ 10.4 B | ||
|
Profound Medical Corp.
PROF
|
0.934 | $ 7.66 | 4.36 % | $ 232 M |